3 news items
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, NYCB, Amylyx, and InMode and Encourages Investors to Contact the Firm
AMLX
INMD
NYCB
25 Mar 24
requirements for the reporting of injuries. Specifically, Defendants repeatedly touted the demand for InMode's devices and told investors that those devices
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, NYCB, Amylyx, and InMode and Encourages Investors to Contact the Firm
AMLX
INMD
NYCB
21 Mar 24
the FDA's prohibition on off-label marketing of devices and the FDA's requirements for the reporting of injuries. Specifically, Defendants repeatedly
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, NYCB, Amylyx, and InMode and Encourages Investors to Contact the Firm
AMLX
INMD
NYCB
17 Mar 24
") regulations, including the FDA's prohibition on off-label marketing of devices and the FDA's requirements for the reporting of injuries
- Prev
- 1
- Next